Lessons in bias: what topical steroid withdrawal studies get wrong
- 23 July 2025
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (11) , 2303-2304
Abstract
Two recent publications sought to address topical steroid withdrawal. The first aimed to characterize the symptoms associated with topical steroid withdrawal, while the second focused on the underlying mechanisms and treatment. We are concerned that basic epidemiological rigour has been violated, as the outcomes of both studies are conditioned on a collider, introducing selection bias that limits generalizability.Keywords
This publication has 5 references indexed in Scilit:
- Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD+Journal of Investigative Dermatology, 2025
- Reported psychiatric adverse events among isotretinoin users: Monitoring priorities from a 20-year FDA Adverse Event Reporting System database studyJournal of the American Academy of Dermatology, 2025
- Topical Steroid Withdrawal: An Emerging Challenge in the Treatment of Atopic DermatitisJournal of Paediatrics and Child Health, 2025
- Topical steroid withdrawal is not a myth. Comment on ‘#corticophobia: a review on online misinformation related to topical steroids’Clinical and Experimental Dermatology, 2023
- Corticosteroid exposure and cumulative effects in patients with eczemaAnnals of Allergy, Asthma & Immunology, 2022